This announcement is a separate document:
Botanix Pharmaceuticals Ltd: FDA Confirms Approach to Sofdra NDA Resubmission
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.